Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell Carcinoma

NCT06988956 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

95

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Nimotuzumab
DRUG: Tegafur
RADIATION: radiotherapy

Sponsor

The First Affiliated Hospital with Nanjing Medical University